HAEMOCOMPLETTAN

This brand name is authorized in Austria, Brazil, Estonia, Netherlands, Romania, Tunisia, Turkey

Active ingredients

The drug HAEMOCOMPLETTAN contains one active pharmaceutical ingredient (API):

1 Human fibrinogen UNII N94833051K - FIBRINOGEN HUMAN

Human fibrinogen (coagulation factor I), in the presence of thrombin, activated coagulation factor XIII (F XIIIa) and calcium ions is converted into a stable and elastic three-dimensional fibrin haemostatic clot. The administration of human fibrinogen concentrate provides an increase in plasma fibrinogen level and can temporarily correct the coagulation defect of patients with fibrinogen deficiency. Read about Human fibrinogen

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
B02BB01	Human fibrinogen	B Blood and blood forming organs → B02 Antihemorrhagics → B02B Vitamin K and other hemostatics → B02BB Fibrinogen
Discover more medicines within B02BB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 502601701151310, 502621010010507, 502621010010607
Country: EE	Ravimiamet	Identifier(s): 1559976
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 118982, 37613
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W13381003
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 8143061H
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8681624980088